Bolt Biotherapeutics (BOLT)
(Delayed Data from NSDQ)
$1.26 USD
+0.14 (12.50%)
Updated May 10, 2024 04:00 PM ET
After-Market: $1.25 -0.01 (-0.79%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -0.51 |
EPS Last Quarter | -0.47 |
Last EPS Surprise | 0.00% |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.68 |
Next Year | -1.07 |
EPS (TTM) | -1.83 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.63M | 2.49M | 8.20M | 37.42M |
# of Estimates | 2 | 2 | 3 | 3 |
High Estimate | 2.80M | 3.05M | 12.53M | 100.00M |
Low Estimate | 2.45M | 1.93M | 1.50M | 1.14M |
Year ago Sales | 1.83M | 1.43M | 7.88M | 8.20M |
Year over Year Growth Est. | 43.44% | 74.13% | 4.15% | 356.13% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.51 | -0.53 | -1.68 | -1.07 |
# of Estimates | 3 | 3 | 4 | 4 |
Most Recent Consensus | -0.47 | -0.49 | -1.96 | -1.72 |
High Estimate | -0.47 | -0.49 | -1.22 | -0.25 |
Low Estimate | -0.57 | -0.59 | -1.96 | -1.72 |
Year ago EPS | -0.45 | -0.48 | -1.83 | -1.68 |
Year over Year Growth Est. | -13.33% | -10.42% | 8.20% | 36.31% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 2 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.51 | -0.53 | -1.68 | -1.07 |
7 Days Ago | -0.51 | -0.53 | -1.68 | -1.07 |
30 Days Ago | -0.51 | -0.53 | -1.68 | -1.07 |
60 Days Ago | NA | NA | -1.75 | -1.38 |
90 Days Ago | NA | NA | -1.75 | -1.38 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.51 | -0.53 | -1.68 | -1.07 |
Zacks Consensus Estimate | -0.51 | -0.53 | -1.68 | -1.07 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.47 | -0.43 | -0.48 | -0.45 | NA |
Estimate | -0.47 | -0.49 | -0.53 | -0.49 | NA |
Difference | 0.00 | 0.06 | 0.05 | 0.04 | 0.04 |
Surprise | 0.00% | 12.24% | 9.43% | 8.16% | 7.46% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more